@brakestar7
actief 1 uur, 39 minuten geleden
n terms of antiviral effectiveness in patients with mild to moderate COVID-19. Furthermore, the combination of RBV and LPV/r is associated with a significant increase in gastrointestinal adverse events, suggesting that RBV and LPV/r should not be co-administered to COVID-19 patients simultaneously.
http://www.ClinicalTrials.gov, ID […] Bekijken
-
Yildirim Guldager heeft een update geplaatst 1 uur, 39 minuten geleden
n terms of antiviral effectiveness in patients with mild to moderate COVID-19. Furthermore, the combination of RBV and LPV/r is associated with a significant increase in gastrointestinal adverse events, suggesting that RBV and LPV/r should not be co-administered to COVID-19 patients simultaneously.
-
Yildirim Guldager is geregistreerd lid geworden 20 uren, 21 minuten geleden
